QA: Eledon Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001404281_2023_Eledon_Pharmaceuticals_Inc.pdf

Logs

Graph

Absolute values for 0001404281, Eledon Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 59,518,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 33,275,000
4 LiabilitiesCurrent 6,475,000
5 LiabilitiesNoncurrent 383,000
6 remainder_Liabilities 1,752,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,700,000
9 ResearchAndDevelopmentExpense 27,080,000
10 remainder_Expenses 48,648,000
11 remainder_Revenues 0
12 remainder_NetIncome 462,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 92,793,000
1 Liabilities 8,610,000
2 Expenses 88,428,000
3 Revenues 0
4 StockholdersEquity 84,183,000
5 NetIncome -87,966,000
6 ComprehensiveNetIncome -87,966,000
7 BaseVar 95,146,500
8 EconomicCapitalRatio 1.12

Edgar->Model Mapping

Feature Distribution

Change over Time